Private equity-firm, TPG Capital, has entered into a definitive agreement to acquire US-based Par Pharmaceutical for US $1.9 billion. Under terms of the agreement, Par stockholders will receive US ...
Par Pharmaceutical's, a subsidiary of Endo International plc, omeprazole and sodium bicarbonate is the generic version of Merck/MSD Consumer Care Inc's Zegerid. "Granules USA, the wholly owned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback